Natural	B:C1566558
product	I:C1566558
derivative	I:C1566558
BIO	B:C1254351
promotes	O
recovery	B:C2004454
after	O
myocardial	B:C0027051
infarction	I:C0027051
via	O
unique	O
modulation	B:C0443264
of	O
the	O
cardiac	B:C0018787
microenvironment	O
.	O

The	O
cardiac	B:C0018787
microenvironment	O
includes	O
cardiomyocytes	B:C0225828
,	O
fibroblasts	B:C0016030
and	O
macrophages	B:C0024432
,	O
which	O
regulate	B:C1327622
remodeling	B:C3658220
after	O
myocardial	B:C0027051
infarction	I:C0027051
(	O
myocardial	B:C0027051
infarction	I:C0027051
)	O
.	O

Targeting	O
this	O
microenvironment	O
is	O
a	O
novel	O
therapeutic	B:C0087111
approach	I:C0087111
for	O
myocardial	B:C0027051
infarction	I:C0027051
.	O

We	O
found	O
that	O
the	O
natural	B:C1566558
compound	I:C1566558
derivative	I:C1566558
,	O
BIO	B:C1254351
(	B:C1254351
(	I:C1254351
2	I:C1254351
'	I:C1254351
Z,3'E	I:C1254351
)	I:C1254351
-	I:C1254351
6	I:C1254351
-	I:C1254351
Bromoindirubin	I:C1254351
-	I:C1254351
3'-	I:C1254351
oxime	I:C1254351
)	I:C1254351
modulated	B:C0443264
the	O
cardiac	B:C0018787
microenvironment	O
to	O
exert	O
a	O
therapeutic	B:C1527144
effect	I:C1527144
on	O
myocardial	B:C0027051
infarction	I:C0027051
.	O

Using	O
a	O
series	O
of	O
co-culture	B:C0282547
studies	I:C0282547
,	O
BIO	B:C1254351
induced	O
proliferation	B:C0596290
in	O
cardiomyocytes	B:C0225828
and	O
inhibited	O
proliferation	B:C0596290
in	O
cardiac	B:C0018787
fibroblasts	B:C0016030
.	O

BIO	B:C1254351
produced	O
multiple	O
anti-fibrotic	B:C0243095
effects	I:C0243095
in	O
cardiac	B:C0018787
fibroblasts	B:C0016030
.	O

In	O
macrophages	B:C0024432
,	O
BIO	B:C1254351
inhibited	O
the	O
expression	O
of	O
pro-inflammatory	O
factors	O
.	O

Significantly	O
,	O
BIO	B:C1254351
modulated	B:C0443264
the	O
molecular	O
crosstalk	B:C0010357
between	O
cardiac	B:C0018787
fibroblasts	B:C0016030
and	O
differentiating	O
macrophages	B:C0024432
to	O
induce	O
polarization	B:C0007613
to	O
the	O
anti-inflammatory	B:C0243095
M2	B:C4086555
phenotype	O
.	O

In	O
the	O
optically	B:C3161035
transparent	I:C3161035
zebrafish	I:C3161035
-	I:C3161035
based	I:C3161035
heart	I:C3161035
failure	I:C3161035
model	I:C3161035
,	O
BIO	B:C1254351
induced	O
cardiomyocyte	B:C0225828
proliferation	B:C0596290
and	O
completely	O
recovered	O
survival	O
rate	O
.	O

BIO	B:C1254351
is	O
a	O
known	O
glycogen	B:C0244988
synthase	I:C0244988
kinase	I:C0244988
-	I:C0244988
3	I:C0244988
Î²	I:C0244988
inhibitor	B:C0243077
,	O
but	O
these	O
effects	O
could	O
not	O
be	O
recapitulated	O
using	O
the	O
classical	B:C0243077
inhibitor	I:C0243077
,	O
lithium	B:C0065088
chloride	I:C0065088
;	O
indicating	O
novel	O
therapeutic	B:C1527144
effects	I:C1527144
of	O
BIO	B:C1254351
.	O

We	O
identified	O
the	O
mechanism	O
of	O
BIO	B:C1254351
as	O
differential	O
modulation	B:C0443264
of	O
p27	B:C0598086
protein	B:C1171362
expression	I:C1171362
and	O
potent	O
induction	O
of	O
anti-inflammatory	B:C0243095
interleukin	B:C0085295
-	I:C0085295
10	I:C0085295
.	O

In	O
a	O
rat	B:C0086272
MI	I:C0086272
model	I:C0086272
,	O
BIO	B:C1254351
reduced	O
fibrosis	B:C0016059
and	O
improved	B:C0184511
cardiac	B:C0018787
performance	O
.	O

Histological	O
analysis	B:C0936012
revealed	O
modulation	B:C0443264
of	O
the	O
cardiac	B:C0018787
microenvironment	O
by	O
BIO	B:C1254351
,	O
with	O
increased	O
presence	B:C0150312
of	O
anti-inflammatory	B:C0243095
M2	B:C4086555
macrophages	I:C4086555
.	O

Our	O
results	O
demonstrate	O
that	O
BIO	B:C1254351
produces	O
unique	O
effects	O
in	O
the	O
cardiac	B:C0018787
microenvironment	O
to	O
promote	O
recovery	B:C2004454
post	O
-	O
MI	O
.	O

